报价延迟最少15分钟:2025/01/21 08:45 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
108.33 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-4.85/-0.70
|
|
企业价值
3.46B
|
| 资产负债 |
|
每股账面净值
2.29
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
492.68M
|
|
每股收益
15.11
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/01/21 08:45 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States. |